[1]
2025. Galactose-Functionalized Solid Lipid Nanoparticles for Site-Specific Hepatic Targeting via the Asialoglycoprotein Receptor: Review Article. Journal of Pharma Insights and Research. 3, 6 (Dec. 2025), 206–213. DOI:https://doi.org/10.69613/4q9mba39.